PAVmed Inc.
PAVM· Nasdaq
Released Aug 13, 2026, after the close
10-Q filed Aug 13, 2026, 44 days after period end · 0001437749-26-027733
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2026 | Q2 2025 | Q2 2024 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $33.00K | $6.00K | $979.00K | $166.00K |
| Net Income | -$5.38M | -$11.92M | -$10.83M | -$14.54M |
| EPS Diluted | -$0.87 |
PAVmed Inc. · CIK 1624326 · Engraved from SEC EDGAR
| -$22.08 |
| -$1.19 |
| -$2.10 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.